<DOC>
	<DOCNO>NCT00848484</DOCNO>
	<brief_summary>This study evaluate safety efficacy study drug compare placebo treatment cognitive impairment men schizophrenia .</brief_summary>
	<brief_title>Treatment Cognitive Impairment Men With Schizophrenia ( MK5757-005 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<criteria>Patient male 21 55 year age Duration illness must longer 1 year Patient 's current antipsychotic medication regimen must stable Patient negative select drug abuse Screening Must stable living arrangement least 3 month prior screen ( homeless shelter ) Patient mental retardation Undergone Electroconvulsive Therapy ( ECT ) treatment within 6 month prior screen Has suicidal attempt ideation within last 12 month Patient history alcohol/drug dependence within 1 year alcohol/drug abuse within 12 month start study</criteria>
	<gender>Male</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>